logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Cidara Therapeutics, Inc.


USPTO Granted Patents = 16



Trademarks = 3

Forward Citations = 83

Loading Chart...
Loading Chart...

30 inventors (with patents filed for the assignee):

goldMedal Balasingam Radhakrishnan (9 out of 38 patents)

silverMedal Kenneth Duke James, Jr (6 out of 11 patents)

bronzeMedal Anuradha Vaidya (6 out of 7 patents)

4.  Kenneth Bartizal (5 out of 6 patents)

5.  Paul Daruwala (5 out of 5 patents)

6.  Allen Borchardt (4 out of 19 patents)

7.  Thanh To Lam (4 out of 11 patents)

8.  Karen Polowy (4 out of 7 patents)

9.  Zhi-Yong Chen (4 out of 4 patents)

10.  Leslie W Tari (4 out of 4 patents)

11.  Navdeep Balkrishna Malkar (4 out of 18 patents)

12.  Thomas P Brady (4 out of 8 patents)

13.  Martin Patrick Hughes (3 out of 6 patents)

14.  David Hughes (3 out of 10 patents)

15.  Voon Ong (3 out of 4 patents)


16 patents:

1. 12569565 - COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS (2026-03-10),
2. 12427200 - Compositions and methods for the treatment of viral infections (2025-09-30),
3. 11833213 - Compositions and methods for the treatment of viral infections (2023-12-05),
4. 11819533 - Compositions and methods for the treatment of fungal infections (2023-11-21),
5. 11712459 - Dosing regimens for treatment of fungal infections (2023-08-01),
6. 11654196 - Dosing regimens for echinocandin class compounds (2023-05-23),
7. 11524980 - Synthesis of echinocandin antifungal agent (2022-12-13),
8. 11510992 - Compositions and methods for the treatment of viral infections (2022-11-29),
9. 11197909 - Compositions and methods for the treatment of fungal infections (2021-12-14),
10. 10780144 - Methods for preventing and treating pneumocystis infections (2020-09-22),
11. 10702573 - Dosing regimens for echinocandin class compounds (2020-07-07),
12. 10369188 - Methods for preventing and treating pneumocystis infections (2019-08-06),
13. 10016479 - Dosing regimens for echinocandin class compounds (2018-07-10),
14. 9676821 - Antifungal agents and uses thereof (2017-06-13),
15. 9526835 - Dosing regimens for echinocandin class compounds (2016-12-27),
Company Overview
Cidara Therapeutics, Inc. is a biotechnology company based in San Diego, California, focused on the development of innovative therapeutics for serious diseases. The company specializes in advancing its proprietary Cloudbreak platform, which aims to enhance the treatment of fungal infections and other serious conditions. Cidara is dedicated to addressing unmet medical needs through its research in antifungal therapies and immunotherapy, striving to improve patient outcomes and expand treatment options in the healthcare landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

Cidara Therapeutics, Inc. USPTO Patent Assignee Logo
16 Patents

#361 in San Diego, CA

#4,770 in California

#19,922 in US

#37,831 in the World

San Diego, CA (US)
San Diego, CA, United States of America

Cidara Therapeutics, Inc.

Forward Citations = 83

30 inventors:

goldMedal Balasingam Radhakrishnan (9 out of 38 patents)

silverMedal Kenneth Duke James, Jr (6 out of 11 patents)

bronzeMedal Anuradha Vaidya (6 out of 7 patents)

4.  Kenneth Bartizal (5 out of 6 patents)

5.  Paul Daruwala (5 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cidara Therapeutics, Inc.. Retrieved from https://idiyas.com/company/cidara-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…